These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24059642)

  • 41. Calcium oxalate crystallization in undiluted postprandial urine of healthy male volunteers as influenced by citrate.
    Fan J; Schwille PO; Schmiedl A; Fink E; Manoharan M
    Arzneimittelforschung; 2001 Oct; 51(10):848-57. PubMed ID: 11715639
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evening primrose oil supplementation increases citraturia and decreases other urinary risk factors for calcium oxalate urolithiasis.
    Rodgers A; Lewandowski S; Allie-Hamdulay S; Pinnock D; Baretta G; Gambaro G
    J Urol; 2009 Dec; 182(6):2957-63. PubMed ID: 19846138
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of dietary potassium citrate supplementation on urine pH and urinary relative supersaturation of calcium oxalate and struvite in healthy dogs.
    Stevenson AE; Wrigglesworth DJ; Smith BH; Markwell PJ
    Am J Vet Res; 2000 Apr; 61(4):430-5. PubMed ID: 10772109
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Parker WR; Asplin JR
    Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Raising urinary citrate lowers calcium oxalate and calcium phosphate crystal formation in whole urine.
    Hallson PC; Rose GA; Sulaiman S
    Urol Int; 1983; 38(3):179-81. PubMed ID: 6868215
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic action of citrate in urolithiasis explained by chemical speciation: increase in pH is the determinant factor.
    Rodgers A; Allie-Hamdulay S; Jackson G
    Nephrol Dial Transplant; 2006 Feb; 21(2):361-9. PubMed ID: 16249202
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of orange juice consumption on urinary stone risk factors.
    Wabner CL; Pak CY
    J Urol; 1993 Jun; 149(6):1405-8. PubMed ID: 8501777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion.
    Domrongkitchaiporn S; Stitchantrakul W; Kochakarn W
    Am J Kidney Dis; 2006 Oct; 48(4):546-54. PubMed ID: 16997050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Calcium citrate: reduced propensity for the crystallization of calcium oxalate in urine resulting from induced hypercalciuria of calcium supplementation.
    Harvey JA; Zobitz MM; Pak CY
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1223-5. PubMed ID: 4055988
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Can the manipulation of urinary pH by beverages assist with the prevention of stone recurrence?
    Siener R
    Urolithiasis; 2016 Feb; 44(1):51-6. PubMed ID: 26614113
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk of calcium oxalate nephrolithiasis in postmenopausal women supplemented with calcium or combined calcium and estrogen.
    Domrongkitchaiporn S; Ongphiphadhanakul B; Stitchantrakul W; Chansirikarn S; Puavilai G; Rajatanavin R
    Maturitas; 2002 Feb; 41(2):149-56. PubMed ID: 11836046
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.
    Robertson WG
    Urolithiasis; 2015 Jan; 43 Suppl 1():93-107. PubMed ID: 25407799
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of 5 different diets on urinary risk factors for calcium oxalate kidney stone formation: evidence of different renal handling mechanisms in different race groups.
    Rodgers AL; Lewandowski S
    J Urol; 2002 Sep; 168(3):931-6. PubMed ID: 12187193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Noncitrus alkaline fruit: a dietary alternative for the treatment of hypocitraturic stone formers.
    Baia Lda C; Baxmann AC; Moreira SR; Holmes RP; Heilberg IP
    J Endourol; 2012 Sep; 26(9):1221-6. PubMed ID: 22500592
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate.
    Pak CY; Peterson R
    Arch Intern Med; 1986 May; 146(5):863-7. PubMed ID: 3963975
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sulfate but not thiosulfate reduces calculated and measured urinary ionized calcium and supersaturation: implications for the treatment of calcium renal stones.
    Rodgers A; Gauvin D; Edeh S; Allie-Hamdulay S; Jackson G; Lieske JC
    PLoS One; 2014; 9(7):e103602. PubMed ID: 25061988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathophysiology-based treatment of idiopathic calcium kidney stones.
    Coe FL; Evan A; Worcester E
    Clin J Am Soc Nephrol; 2011 Aug; 6(8):2083-92. PubMed ID: 21825103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of calcium citrate supplementation on urinary calcium oxalate saturation in female stone formers: implications for prevention of osteoporosis.
    Levine BS; Rodman JS; Wienerman S; Bockman RS; Lane JM; Chapman DS
    Am J Clin Nutr; 1994 Oct; 60(4):592-6. PubMed ID: 8092096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.